Lektac
150 mg № 10, № 20, № 30
Pharmacotherapeutic group
Active ingredient
Ranitidine
Pharmaceutical form
Coated tablets
ATC code
A02BA02
RX/OTC
RX
General properties
Pharmacotherapeutic group
Drugs for peptic ulcer and gastro-oesophageal reflux disease. H2 receptor antagonists. Ranitidine.
Therapeutic indications
- Gastric and duodenal peptic ulcer, not associated with Helicobacter pylori (in the acute phase), including an ulcer associated with the administration of non-steroidal anti-inflammatory drugs (NSAIDs);
- functional dyspepsia;
- chronic gastritis with increased acid-forming function of the stomach in the acute stage;
- gastro-oesophageal reflux disease (to relieve symptoms) or reflux oesophagitis.
Contraindications
Individual hypersensitivity to ranitidine and other components of the drug; presence of malignant diseases of the stomach, cirrhosis of the liver with a history of portosystemic encephalopathy; severe renal failure (creatinine clearance <30 ml/min).
Pharmaceutical characteristics
Main physicochemical properties
Light orange to orange round, biconvex, coated tablets. A core surrounded by one continuous layer seen on a score under a magnifying glass.
Shelf life
3 years.
Storage
Store in the original packaging below 30 °С.
Keep away from children.
Manufacturer
PJSC «Technolog».
Location
Building 8, Stara Prorizna Street, Uman City Cherkasy region, 20300, Ukraine.
